Association studies of genetic variants and obesity and/or obesity-related risk
factors have yielded contradictory results. The aim of the present study was to
determine the possible association of five single-nucleotide polymorphisms (SNPs)
located in the IGF2, LEPR, POMC,
PPARG, and PPARGC1genes with obesity or
obesity-related risk phenotypes. This case-control study assessed overweight (n=192)
and normal-weight (n=211) children and adolescents. The SNPs were analyzed using
minisequencing assays, and variables and genotype distributions between the groups
were compared using one-way analysis of variance and Pearson's chi-square or Fisher's
exact tests. Logistic regression analysis adjusted for age and gender was used to
calculate the odds ratios (ORs) for selected phenotype risks in each group. No
difference in SNP distribution was observed between groups. In children, POMC
rs28932472(C) was associated with lower diastolic blood
pressure (P=0.001), higher low-density lipoprotein (LDL) cholesterol (P=0.014), and
higher risk in overweight children of altered total cholesterol (OR=7.35, P=0.006).
In adolescents, IGF2 rs680(A) was associated with
higher glucose (P=0.012) and higher risk in overweight adolescents for altered
insulin (OR=10.08, P=0.005) and homeostasis model of insulin resistance (HOMA-IR)
(OR=6.34, P=0.010). PPARG rs1801282(G) conferred a
higher risk of altered insulin (OR=12.31, P=0.003), and HOMA-IR (OR=7.47, P=0.005) in
overweight adolescents. PARGC1 rs8192678(A) was
associated with higher triacylglycerols (P=0.005), and LEPR
rs1137101(A) was marginally associated with higher LDL
cholesterol (P=0.017). LEPR rs1137101(A) conferred
higher risk for altered insulin, and HOMA-IR in overweight adolescents. The
associations observed in this population suggested increased risk for cardiovascular
diseases and/or type 2 diabetes later in life for individuals carrying these
alleles.